What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
His primary areas of study are Ophthalmology, Odds ratio, Surgery, Internal medicine and Eye disease.
As part of one scientific family, Paul Mitchell deals mainly with the area of Ophthalmology, narrowing it down to issues related to the Maculopathy, and often Drusen.
His work carried out in the field of Odds ratio brings together such families of science as Age-related maculopathy and Confidence interval.
His research on Surgery also deals with topics like
- Cohort study, which have a strong connection to Incidence and Relative risk,
- Retinopathy which intersects with area such as Diabetic retinopathy.
His Internal medicine research is multidisciplinary, relying on both Diabetes mellitus, Endocrinology and Cardiology.
His Eye disease study integrates concerns from other disciplines, such as Epiretinal membrane, Pediatrics, Eye examination and Cataract surgery.
His most cited work include:
- Global Prevalence and Major Risk Factors of Diabetic Retinopathy (2033 citations)
- Causes and prevalence of visual impairment among adults in the United States. (2007 citations)
- Prevalence of Age-related Maculopathy in Australia: The Blue Mountains Eye Study (947 citations)
What are the main themes of his work throughout his whole career to date?
Paul Mitchell focuses on Ophthalmology, Internal medicine, Surgery, Odds ratio and Macular degeneration.
His work in Ophthalmology covers topics such as Optometry which are related to areas like Refractive error.
His research integrates issues of Diabetes mellitus, Endocrinology, Oncology and Cardiology in his study of Internal medicine.
His Surgery research incorporates elements of Stroke and Risk factor.
His work in Odds ratio tackles topics such as Confidence interval which are related to areas like Demography.
His study in Macular degeneration is interdisciplinary in nature, drawing from both Maculopathy, Epidemiology and Age related.
He most often published in these fields:
- Ophthalmology (29.99%)
- Internal medicine (29.36%)
- Surgery (14.93%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (29.36%)
- Macular degeneration (13.17%)
- Ophthalmology (29.99%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Macular degeneration, Ophthalmology, Incidence and Lung cancer.
His Internal medicine study combines topics in areas such as Diabetic retinopathy and Oncology.
His Macular degeneration research includes elements of Ranibizumab, Visual acuity and Age related.
The concepts of his Visual acuity study are interwoven with issues in Visual impairment, Prospective cohort study and Randomized controlled trial.
The Ophthalmology study combines topics in areas such as Retina and Aflibercept.
His Confidence interval study frequently draws connections between related disciplines such as Odds ratio.
Between 2016 and 2021, his most popular works were:
- Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (145 citations)
- Rare and low-frequency coding variants alter human adult height (126 citations)
- The Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration (109 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
Paul Mitchell mainly investigates Internal medicine, Macular degeneration, Diabetic retinopathy, Ophthalmology and Genome-wide association study.
His studies deal with areas such as Single-nucleotide polymorphism and Surgery as well as Internal medicine.
His Macular degeneration research integrates issues from Incidence, Systematic review, Ranibizumab, Age related and Cohort.
His studies in Diabetic retinopathy integrate themes in fields like Blood pressure, Severity of illness and Type 2 diabetes.
His study connects Retina and Ophthalmology.
His Diabetes mellitus research incorporates themes from Prospective cohort study and Retinal.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
